Ophthotech Reports Second Quarter 2015 Financial and Operating Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
UPDATE: Goldman Sachs Expects Underperformance at Ophthotech (OPHT), Cuts to Sell
August 7, 2015 7:02 AM EDT(Updated - August 7, 2015 9:40 AM EDT)
Goldman Sachs downgraded Ophthotech Corp (NASDAQ: OPHT) from Neutral to Sell with a price target of $45 (unchanged). Analyst Terence Flynn expects share price underperformance due to competitor updates, as well as lack of meaningful catalysts.
"One of the tenants to our thesis has been potential future competition... More
Ophthotech Corp (OPHT) Misses Q2 EPS by 6c
August 5, 2015 7:34 AM EDTOphthotech Corp (NASDAQ: OPHT) reported Q2 EPS of ($1.08), $0.06 worse than the analyst estimate of ($1.02). Revenue for the quarter came in at $1.6 million versus the consensus estimate of $2.77 million.
For earnings history and earnings-related data on Ophthotech Corp (OPHT) click here.
... More